focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Share News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.50
Bid: 5.00
Ask: 6.00
Change: 0.00 (0.00%)
Spread: 1.00 (20.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.50
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Braveheart Sells Im-Sense Investment For GBP0.3M, Sees More Disposals

Fri, 16th Jul 2010 07:37

LONDON (Dow Jones)--Braveheart Investment Group PLC (BRH.LN), a technology commercialization and investment management company, Friday announces that it has realized its investment in one of its portfolio companies, Im-Sense Ltd, as a result of the acquisition of that company by an undisclosed trade buyer for a cash consideration. MAIN FACTS: -Braveheart acquired its minority shareholding in Im-Sense, an image signal processing technology spin-out from the University of East Anglia, in June 2008 for a cost of GBP150,000 and will receive a cash consideration from the disposal of its investment of GBP342,000. -The sale proceeds will be reinvested in new opportunities or used for working capital purposes. -A number of Braveheart's investment clients also realized their shareholding in Im-Sense on the same terms. -After three years, portfolio is maturing in line with expectations -There are more and better exits to come -Expects that subject to the market being receptive, will be realizing a number of investments over the next two years. -Shares closed Thursday at 22.0 pence. By Iain Packham, Dow Jones Newswires; 44-20-7842-9269; iain.packham@dowjones.com (END) Dow Jones Newswires July 16, 2010 02:37 ET (06:37 GMT)
More News
17 May 2024 18:45

TRADING UPDATES: Braveheart writes down value of two investments

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
6 Mar 2024 14:14

IN BRIEF: Braveheart buys 4 million Autins shares for GBP320,000

Braveheart Investment Group PLC - Dodworth, England-based investment company - Between Monday and Tuesday, buys a further 4.0 million shares in Autins Group PLC at an average price of 8 pence per share, for a total of GBP320,000. Following this, now holds 23% of the issued share capital of Autins.

Read more
6 Mar 2024 13:56

Braveheart takes Autins stake to over 23pc

(Sharecast News) - Braveheart Investment Group announced a significant increase in its ownership stake in Autins Group on Wednesday.

Read more
4 Mar 2024 19:59

TRADING UPDATES: Beowulf raises funds for Kallak iron ore project

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
4 Mar 2024 14:47

Braveheart to retain Paraytec after failing to find buyer

(Sharecast News) - Braveheart Investment Group updated the market on one of its key investments, Paraytec, on Monday, confirming that it had failed to find an appropriate buyer for the company.

Read more
4 Mar 2024 14:29

TRADING UPDATES: Beowulf ups Vardar stake; Impellam buyout nears

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
22 Dec 2023 14:26

IN BRIEF: Braveheart Investment to sell Phasefocus for GBP5 million

Braveheart Investment Group PLC - Dodworth, England-based investment company - Announces conditional sale of Phasefocus Holdings Ltd to analytics instrumentation company Bruker UK Ltd for GBP5 million. Once closing conditions are satisfied, Braveheart expects completion of the sale to occur in the first quarter of 2024. Consideration will be payable in cash and represent GBP17.74 per Phasefocus share. Braveheart currently holds 48.3% of Phasefocus's issued share capital. Estimates that it will receive total sale proceeds of approximately GBP2.1 million after expenses. Braveheart says board is still considering whether to use proceeds to continue support further investments in technology-based companies, or whether to redistribute the proceeds via a special dividend.

Read more
15 Dec 2023 21:09

EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
14 Dec 2023 17:20

EARNINGS AND TRADING: abrdn Diversified Income to begin wind-down

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Nov 2023 16:32

Braveheart Investment firm gets first CX300 detector sales contract

(Alliance News) - Braveheart Investment Group PLC on Wednesday said its wholly-owned portfolio company Paraytec Ltd has secured its first commercial sales contract for the CX300 Optical Particle detector instrument.

Read more
17 Oct 2023 17:03

IN BRIEF: Braveheart Investment investee Paraytec updates on CX300

Braveheart Investment Group PLC - Dodworth, England-based investment company - Investee company Paraytec Ltd updates on its work in the development of potential use cases for its rapid test instrument, CX300. Explains it has been successfully tested in the detection of adeno-associated viruses, which are used in gene therapy. Notes this is important because virus-like particles such as adeno-associated viruses are used to encapsulate the new gene and deliver it into the body. Points out the target is to market the CX300 for use by all gene therapy manufacturers for in-process assessment of the quality of their adeno-associated virus products during research, development and, in due course, manufacturing.

Read more
8 Sep 2023 14:07

Braveheart upbeat on investee's brain research breakthrough

(Sharecast News) - Braveheart Investment Group updated the market on the progress of its investee company Kirkstall on Friday, including a recent breakthrough in the study of the human blood-brain barrier and its interaction with brain cancer.

Read more
8 Sep 2023 11:42

IN BRIEF: Braveheart Investment investee Kirkstall develops new model

Braveheart Investment Group PLC - Dodworth, England-based investment company - Updates on Kirkstall Ltd, a company within its investment portfolio. Says Kirkstall, in conjunction with the Biomedical Ultrasonics, Biotherapy & Biopharmaceutical Laboratory within the Institute of Biomedical Engineering at the University of Oxford, has developed an "organ on a chip" model of a milli-fluidic system, human blood-brain barrier which has been used to map the interaction between the blood-brain barrier and brain cancer. Explains this is the first time a dynamic milli-fluidic model has been developed where the interactions between the blood-brain barrier and medulloblastoma brain cancer spheroids have been demonstrated.

Read more
21 Aug 2023 10:14

Braveheart invests GBP150,000 in Phasefocus for cancer-focused assay

(Alliance News) - Braveheart Investment Group PLC on Monday said it has invested more in Phasefocus Holdings Ltd, a Sheffield-based company that develops products that quantify and compare dynamic live cell behaviour.

Read more
28 Jul 2023 20:46

TRADING UPDATES: Limitless Earth loss widens; Black Sea NAV rises

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.